{"prompt": "['CIP HD01-16-30', 'HHELSINN', 'Version 1.0, 06/02/2017', 'and must be duly qualified. It must take into consideration the laws and regulations of the country or', 'countries in which the research is to be performed as well as applicable international norms and', 'standards but these must not be allowed to reduce or eliminate any of the protections for research', 'subjects set forth in this Declaration.', 'The committee must have the right to monitor ongoing studies. The researcher must provide', 'monitoring information to the committee, especially information about any serious adverse events. No', 'amendment to the protocol may be made without consideration and approval by the committee. After', 'the end of the study, the researchers must submit a final report to the committee containing a summary', \"of the study's findings and conclusions.\", 'Privacy and Confidentiality', '24.', 'Every precaution must be taken to protect the privacy of research subjects and the confidentiality', 'of their personal information.', 'Informed Consent', '25.', 'Participation by individuals capable of giving informed consent as subjects in medical research', 'must be voluntary. Although it may be appropriate to consult family members or community leaders,', 'no individual capable of giving informed consent may be enrolled in a research study unless he or she', 'freely agrees.', '26.', 'In medical research involving human subjects capable of giving informed consent, each potential', 'subject must be adequately informed of the aims, methods, sources of funding, any possible conflicts of', 'interest, institutional affiliations of the researcher, the anticipated benefits and potential risks of the', 'study and the discomfort it may entail, post-study provisions and any other relevant aspects of the study.', 'The potential subject must be informed of the right to refuse to participate in the study or to withdraw', 'consent to participate at any time without reprisal. Special attention should be given to the specific', 'information needs of individual potential subjects as well as to the methods used to deliver the', 'information.', 'After ensuring that the potential subject has understood the information, the physician or another', \"appropriately qualified individual must then seek the potential subject's freely-given informed consent,\", 'preferably in writing. If the consent cannot be expressed in writing, the non-written consent must be', 'formally documented and witnessed.', 'All medical research subjects should be given the option of being informed about the general', 'outcome and results of the study.', '27.', 'When seeking informed consent for participation in a research study the physician must be', 'particularly cautious if the potential subject is in a dependent relationship with the physician or may', 'consent under duress. In such situations the informed consent must be sought by an appropriately', 'qualified individual who is completely independent of this relationship.', '28.', 'For a potential research subject who is incapable of giving informed consent, the physician must', 'seek informed consent from the legally authorised representative. These individuals must not be', 'included in a research study that has no likelihood of benefit for them unless it is intended to promote', 'CONFIDENTIAL', 'Page 51 of 53']['CIP HD01-16-30', 'HHELSINN', 'Version 1.0, 06/02/2017', 'the health of the group represented by the potential subject, the research cannot instead be performed', 'with persons capable of providing informed consent, and the research entails only minimal risk and', 'minimal burden.', '29.', 'When a potential research subject who is deemed incapable of giving informed consent is able', 'to give assent to decisions about participation in research, the physician must seek that assent in', \"addition to the consent of the legally authorised representative. The potential subject's dissent should\", 'be respected.', '30.', 'Research involving subjects who are physically or mentally incapable of giving consent, for', 'example, unconscious patients, may be done only if the physical or mental condition that prevents giving', 'informed consent is a necessary characteristic of the research group. In such circumstances the', 'physician must seek informed consent from the legally authorised representative. If no such', 'representative is available and if the research cannot be delayed, the study may proceed without', 'informed consent provided that the specific reasons for involving subjects with a condition that renders', 'them unable to give informed consent have been stated in the research protocol and the study has been', 'approved by a research ethics committee. Consent to remain in the research must be obtained as soon', 'as possible from the subject or a legally authorised representative.', '31.', 'The physician must fully inform the patient which aspects of their care are related to the', \"research. The refusal of a patient to participate in a study or the patient's decision to withdraw from\", 'the study must never adversely affect the patient-physician relationship.', '32. For medical research using identifiable human material or data, such as research on material or', 'data contained in biobanks or similar repositories, physicians must seek informed consent for its', 'collection, storage and/or reuse. There may be exceptional situations where consent would be', 'impossible or impracticable to obtain for such research. In such situations the research may be done', 'only after consideration and approval of a research ethics committee.', 'Use of Placebo', '33.', 'The benefits, risks, burdens and effectiveness of a new intervention must be tested against those', 'of the best proven intervention(s), except in the following circumstances:', 'Where no proven intervention exists, the use of placebo, or no intervention, is acceptable; or', 'Where for compelling and scientifically sound methodological reasons the use of any intervention', 'less effective than the best proven one, the use of placebo, or no intervention is necessary to determine', 'the efficacy or safety of an intervention and the patients who receive any intervention less effective than', 'the best proven one, placebo, or no intervention will not be subject to additional risks of serious or', 'irreversible harm as a result of not receiving the best proven intervention.', 'Extreme care must be taken to avoid abuse of this option.', 'Post-Trial Provisions', 'CONFIDENTIAL', 'Page 52 of 53']\n\n###\n\n", "completion": "END"}